Bayer’s Innovative PET Blister Pack

Highlights

• Bayer has launched a unique PET blister pack for its Aleve drug brand, claiming it creates 38% less carbon emissions than conventional
• The innovative product is expected to surpass hard-to-recycle alternatives

Bayer has introduced a unique healthcare packaging solution for Aleve, utilising polyethylene terephthalate (PET) blister packaging. This innovative packaging, developed in partnership with Liveo Research, promotes environmental stewardship by eliminating the use of PVC.

Blister packaging, a major environmental concern due to its multilayer plastic and aluminum composition, is set to be replaced with more sustainable alternatives. The company, starting its launch in the Netherlands, aims to replace all blister packaging with these alternatives in the coming years.

The new blister packaging reduces its carbon footprint by 38% per unit, decreases biodiversity loss by 78%, uses 53% less water, requires 18% less land, and lightens the package by 18% compared to its current packaging.

According to Chris Padain, Vice President and Global Head of Design, Packaging, Product Experience, and Sustainability for Bayer’s Consumer Health Division, the company intends to transform its packaging to provide exceptional consumer experiences while reducing environmental impact and developing circular solutions. This initiative represents a significant step towards environmental sustainability by reducing carbon footprint and water usage.

Bayer is collaborating with the Global Self-Care Federation, Blister Pack Collective, and The Recycling Partnership to accelerate progress in non-prescription medicine packaging. The company is researching new packaging methods, designing circular packaging solutions, and collaborating with partners to innovate packaging and improve recycling infrastructure. These efforts aim to maintain product efficacy, quality, and safety.